Deerfield Management Company, L.P. 的 Form 4 申報
Nuvalent, Inc.（NUVL），2025/11/24 申報
- 申報編號
- 0001193805-25-001648
- 申報時間
- 2025/11/24 20:00 ET
- 交易日
- 2025/11/24
- 申報延遲
- 當天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 2 筆非衍生性交易。公開市場賣出合計 $7,087 萬。交易當天就申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Deerfield Management Company, L.P.CIK 0001009258 | 董事、持股 10% 以上大股東、其他：Director by Deputization |
| Deerfield Mgmt L.P.CIK 0001010823 | 董事、持股 10% 以上大股東、其他：Director by Deputization |
| Deerfield Partners, L.P.CIK 0001301041 | 董事、持股 10% 以上大股東、其他：Director by Deputization |
| Flynn James ECIK 0001352546 | 董事、持股 10% 以上大股東、其他：Director by Deputization |
| Deerfield Healthcare Innovations Fund, L.P.CIK 0001646981 | 董事、持股 10% 以上大股東、其他：Director by Deputization |
| Deerfield Mgmt HIF, L.P.CIK 0001665736 | 董事、持股 10% 以上大股東、其他：Director by Deputization |
| Deerfield Private Design Fund IV, L.P.CIK 0001680307 | 董事、持股 10% 以上大股東、其他：Director by Deputization |
| Deerfield Mgmt IV, L.P.CIK 0001713467 | 董事、持股 10% 以上大股東、其他：Director by Deputization |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The shares of Class A Common Stock were sold to underwriters pursuant to the exercise of the underwriters' option to purchase shares of Class A Common Stock from Deerfield Private Design Fund IV, L.P. and Deerfield Healthcare Innovations Fund, L.P., at a price per share of $95.445, to cover over-allotments in an underwritten public offering. The shares were sold to the public in the offering at a price of $101.00 per share.
表 I 有 2 筆交易的價格引用這則附註。
備註
Each of Cameron Wheeler, a partner in Deerfield Management, and Joseph Pearlberg, an employee of Deerfield Management, serves as a director of the Issuer. Jonathan Isler, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24 to a Form 3 with regard to BiomX Inc. filed with the Securities and Exchange Commission on March 19, 2024 by Deerfield Private Design Fund V, L.P., Deerfield Healthcare Innovations Fund II, L.P., Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P., Deerfield Management Company, L.P. and James E. Flynn.